Skip to main content
SpringerLink
Log in

Growth hormone treatment improves final height and nutritional status of children with chronic kidney disease and growth deceleration

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

Growth retardation is a common complication of chronic kidney disease (CKD) in children. Treatment with recombinant human growth hormone (rhGH) has been used to help short children with CKD to attain a height more in keeping with their age group, but the scientific evidence regarding the effect of rhGH on final height is scarce.

Methods

Final heights of children with CKD receiving rhGH treatment (cases) were compared with final heights of a matched cohort of children with CKD that did not receive rhGH therapy (controls).

Results

Sixty-eight rhGH-treated cases (44 boys) were compared with 92 untreated controls (60 boys). Mean duration of rhGH therapy was 4.2 ± 0.9 years; rhGH dose was 0.3 ± 0.07 mg/kg/week. Height SDS at baseline was lower in rhGH-treated patients than in controls (−2.00 ± 1.02 versus −0.96 ± 1.11, p < 0.001). Baseline height SDS was significantly lower than target height SDS in both groups. Height SDS significantly improved from baseline to final height attainment in rhGH-treated patients, while it slightly decreased in controls (mean SDS variation 0.69 ± 1.05 in rhGH-treated cases versus −0.15 ± 1.2 in controls). Final height SDS was −1.25 ± 1.06 in rhGH-treated cases and −1.06 ± 1.17 in controls (p = 0.29). Target adjusted final height SDS was −0.91 ± 1.03 in rhGH-treated cases and −0.61 ± 1.17 in controls (p = 0.1).

Conclusions

Long-term rhGH therapy is able to reduce the linear growth deceleration of children with CKD, and ultimately to improve their final height, reducing the difference with target height.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD work group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:136–150

    Article  Google Scholar 

  2. Mahesh S, Kaskel F (2008) Growth hormone axis in chronic kidney disease. Pediatr Nephrol 23:41–48

    Article  PubMed  Google Scholar 

  3. Harambat J, Cochat P (2009) Growth after renal transplantation. Pediatr Nephrol 24:1297–1306

    Article  PubMed  Google Scholar 

  4. Mahan JD, Warady BA (2006) Consensus Committee. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 21:917–930

    Article  PubMed  Google Scholar 

  5. Hodson EM, Willis NS, Craig JC (2012) Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. doi:10.1002/14651858.CD003264.pub3

    Google Scholar 

  6. Nissel R, Lindberg A, Mehls O, Haffner D, Pfizer International Growth Database (KIGS) International Board (2008) Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease. J Clin Endocrinol Metab 93:1359–1365

    Article  CAS  PubMed  Google Scholar 

  7. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. N Engl J Med 343:923–930

    Article  CAS  PubMed  Google Scholar 

  8. Fine RN, Stablein D (2005) Long term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS transplant Registry. Pediatr Nephrol 20:404–408

    Article  PubMed  Google Scholar 

  9. Bérard E, André JL, Guest G, Berthier F, Afanetti M, Cochat P, Broyer M, French Society for Pediatric Nephrology (2008) Long-term result s of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology. Pediatr Nephrol 23:2031–2038

    Article  PubMed  Google Scholar 

  10. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590

    Article  CAS  PubMed  Google Scholar 

  11. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593

    Article  CAS  PubMed  Google Scholar 

  12. Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170–179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tanner JM, Goldstein H, Whitehouse RH (1970) Standards for children’s height at age 2 to 9 years allowing for height of parents. Arch Dis Child 45:819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Broyer M (1996) Results and side-effects of treating children with growth hormone after kidney transplantation—a preliminary report. Pharmacia & Upjohn Study Group. Acta Paediatr Suppl 417:76–79

    Article  CAS  PubMed  Google Scholar 

  15. Fine RN, Kohaut EC, Brown D, Perlman AJ (1994) Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 124(3):374–382

    Article  CAS  PubMed  Google Scholar 

  16. Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696

    Article  CAS  PubMed  Google Scholar 

  17. Kuizon BD, Goodman WG, Gales B, Juppner H, Salusky IB (1998) Effects of growth hormone on bone and mineral metabolism in dialyzed children. J Am Soc Nephrol 9:546–547

    Google Scholar 

  18. Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology. Arch Disease Child 79:481–487

    Article  CAS  Google Scholar 

  19. Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 51:1970–1979

    Article  CAS  PubMed  Google Scholar 

  20. Sanchez CP, Kuizon BD, Goodman WG, Gales B, Ettenger RB, Boechat MI, Wang Y, Elashoff R, Salusky IB (2002) Growth hormone and the skeleton in pediatric renal allograft recipients. Pediatric Nephrology 17:322–328

    Article  PubMed  Google Scholar 

  21. Santos F, Moreno ML, Neto A, Ariceta G, Vara J, Alonso A, Bueno A, Afonso AC, Correia AJ, Muley R, Barrios V, Gómez C, Argente J (2010) Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial. Clin J Am Soc Nephrol 5:1190–1197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Wit JM, Wolff ED, de Jong MC et al (1991) Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338:585–590

    Article  CAS  PubMed  Google Scholar 

  23. Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL (1996) A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl 53:128–134

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Endocrinology and Diabetes, Bambino Gesù Children’s Hospital, IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy

    C. Bizzarri & M. Cappa

  2. Department of Biomedicine and Human Oncology/Pediatric Section, University A. Moro, Bari, Italy

    A. Lonero, M. Delvecchio, L. Cavallo & M. F. Faienza

  3. Pediatric Nephrology and Dialysis Unit, Children’s Hospital Giovanni XXIII, Bari, Italy

    M. Giordano

  4. Unit of Pediatric Nephrology and Renal Transplant, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

    L. Dello Strologo

Authors
  1. C. Bizzarri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lonero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Delvecchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Cavallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. F. Faienza
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Dello Strologo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Cappa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Bizzarri.

Ethics declarations

Financial disclosure

No funding.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

Research involving human participants and/or animals is not applicable because it is a retrospective study.

Informed consent

For this type of retrospective study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bizzarri, C., Lonero, A., Delvecchio, M. et al. Growth hormone treatment improves final height and nutritional status of children with chronic kidney disease and growth deceleration. J Endocrinol Invest 41, 325–331 (2018). https://doi.org/10.1007/s40618-017-0745-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0745-4

Keywords

Search

Navigation